Company Description
Magdent technology enables dentists in dental implant procedures to shorten the healing process by up to 3 times, improve bone-to-implant connection and increase osseointegration. The company aims to set a new standard of care for dentists and patients around the world. Magdent utilized pulse electromagnetic fields, a clinically proven treatment method commonly used in orthopedics and FDA approved since 1979, and developed a Miniaturized Electromagnetic Device (MED), which is shaped exactly like simple healing caps and can fit with 85% of the implants sold globally. The MED also has proven success even when inflammation is present, which is the #1 cause of pain in the industry, and has the potential to help millions of patients, allowing a treatment for peri-implantitis. In addition, patients with poor bone quality (including those who smoke and people with smoking, diabetes, oral inflammatory conditions, osteoporosis, and cancer) and those prone to recurrent oral infections are at risk of implant failures. Robust evidence shows that the Magdent-MED increases bone volume density by 62%, thus making it the treatment of choice for patients with this high failure risk. Magdent’s target market is dental implant procedures. There are approximately 17M dental implants used globally each year, about 12M of them in the US and Europe.
The details here are based on information received from, and verified solely by, the company.
